Wei Li

Dr. Li is the Interim CEO of QuantX Biosciences, and a Founding Partner of Creacion Ventures. Previously, he served as Managing Partner at 6 Dimensions Capital, Founding Partner of WuXi Healthcare Ventures, and Executive Partner at Fidelity Biosciences.

A seasoned entrepreneur and investor, Dr. Li has successfully established numerous biopharmaceutical companies worldwide. He played a pivotal role in founding Innovent Biologics, served as the founding director of CStone Pharmaceuticals, and contributed to the creation of OcuMension Therapeutics and Dewpoint Therapeutics. Dr. Li earned his Ph.D. from Harvard University and an MBA from the Kellogg School of Management at Northwestern University.